{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:29Z","timestamp":1791357389111,"version":"4.3.1"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1080\/10673220801924308","type":"journal-article","created":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T17:40:57Z","timestamp":1204134057000},"page":"13-24","source":"Crossref","is-referenced-by-count":52,"title":["Hyponatremia in Psychiatric Patients: Update on Evaluation and Management"],"prefix":"10.1097","volume":"16","author":[{"given":"Arthur J.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia.","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMcpc049016","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values.","volume":"351","author":"Kratz","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis.","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"issue":"7A","key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjmed.2006.05.002","article-title":"Mechanisms of cell volume regulation in hypo-osmolality.","volume":"119","author":"Pasantes-Morales","year":"2006","journal-title":"Am J Med"},{"issue":"7A","key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2006.05.003","article-title":"Brain volume regulation in response to hypo-osmolality and its correction.","volume":"119","author":"Sterns","year":"2006","journal-title":"Am J Med"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000086019","article-title":"Consequences of inadequate management of hyponatremia.","volume":"25","author":"Adrogue","year":"2005","journal-title":"Am J Nephrol"},{"key":"R7-2-20210129","first-page":"335","article-title":"Predictors of outcome in hospitalized patients with severe hyponatremia.","volume":"95","author":"Nzerue","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0749-0704(05)70149-4","article-title":"Syndromes of excess antidiuretic hormone release.","volume":"17","author":"Miller","year":"2001","journal-title":"Crit Care Clin"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0025-7125(05)70535-6","article-title":"Hyponatremia and hypernatremia.","volume":"81","author":"Fried","year":"1997","journal-title":"Med Clin North Am"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits.","volume":"119","author":"Renneboog","year":"2006","journal-title":"Am J Med"},{"issue":"7A","key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.amjmed.2006.05.013","article-title":"Is asymptomatic hyponatremia really asymptomatic.","volume":"119","author":"Decaux","year":"2006","journal-title":"Am J Med"},{"issue":"7A","key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amjmed.2006.05.010","article-title":"Mechanisms and therapy of osmotic demyelination.","volume":"119","author":"Murase","year":"2006","journal-title":"Am J Med"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/ndt\/gfg394","article-title":"The pathophysiology and treatment of hyponatraemic encephalopathy: an update.","volume":"18","author":"Moritz","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R14-2-20210129","first-page":"3","article-title":"Adaptation to acute and chronic hyponatremia: implications for symptomatology, diagnosis, and therapy.","volume":"18","author":"Verbalis","year":"1998","journal-title":"Semin Nephrol"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1681\/ASN.V12suppl_1s10","article-title":"Treatment of severe hyponatremia: conventional and novel aspects.","volume":"12","author":"Gross","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin.","volume":"102","author":"Anderson","year":"1985","journal-title":"Ann Intern Med"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02596422","article-title":"The prognosis of hyponatremia at hospital admission.","volume":"1","author":"Tierney","year":"1986","journal-title":"J Gen Intern Med"},{"issue":"7A","key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia.","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00406-003-0403-z","article-title":"Polydipsia. A study in a long-term psychiatric unit.","volume":"253","author":"de Leon","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198802183180702","article-title":"Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia.","volume":"318","author":"Goldman","year":"1988","journal-title":"N Engl J Med"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10673229809000329","article-title":"Primary and drug-induced disorders of water homeostasis in psychiatric patients: principles of diagnosis and management.","volume":"6","author":"Siegel","year":"1998","journal-title":"Harv Rev Psychiatry"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9343(96)00274-4","article-title":"Epidemiology, pathophysiology, and management of hyponatremic encephalopathy.","volume":"102","author":"Fraser","year":"1997","journal-title":"Am J Med"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0033-3182(91)72084-7","article-title":"A review of disorders of water homeostasis in psychiatric patients.","volume":"32","author":"Riggs","year":"1991","journal-title":"Psychosomatics"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0889-8529(01)00007-X","article-title":"Systemic diseases associated with disorders of water homeostasis.","volume":"31","author":"Wong","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0889-8529(18)30422-5","article-title":"Disorders of antidiuretic hormone.","volume":"17","author":"Vokes","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R26-2-20210129","first-page":"625","article-title":"Management of the syndrome of inappropriate secretion of antidiuretic hormone.","volume":"6","author":"Kinzie","year":"1987","journal-title":"Clin Pharm"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00002018-199512030-00006","article-title":"Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.","volume":"12","author":"Spigset","year":"1995","journal-title":"Drug Saf"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","article-title":"Disorders of body water homeostasis.","volume":"17","author":"Verbalis","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone. Normal and disordered function.","volume":"30","author":"Robertson","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1345\/aph.1G209","article-title":"Carbamazepine-induced hyponatremia: assessment of risk factors.","volume":"39","author":"Kuz","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17843286.2000.11754274","article-title":"Hyponatremia in the intensive care: from diagnosis to treatment.","volume":"55","author":"Decaux","year":"2000","journal-title":"Acta Clin Belg"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone.","volume":"42","author":"Bartter","year":"1967","journal-title":"Am J Med"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1152\/ajpendo.00033.2004","article-title":"Downward resetting of the osmotic threshold for thirst in patients with SIADH.","volume":"287","author":"Smith","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-595X(85)80065-7","article-title":"Disorders of antidiuretic hormone secretion.","volume":"14","author":"Robinson","year":"1985","journal-title":"Clin Endocrinol Metab"},{"issue":"7A","key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2006.05.004","article-title":"Whole-body volume regulation and escape from antidiuresis.","volume":"119","author":"Verbalis","year":"2006","journal-title":"Am J Med"},{"key":"R36-2-20210129","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0883-9417(90)90049-Q","article-title":"The water-intoxicated patient.","volume":"4","author":"Cosgray","year":"1990","journal-title":"Arch Psychiatr Nurs"},{"key":"R37-2-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(96)02986-1","article-title":"The psychobiology of eating behavior in anorexia nervosa.","volume":"62","author":"Halmi","year":"1996","journal-title":"Psychiatry Res"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0025-7125(05)70272-8","article-title":"Eating disorders in adolescents and young adults.","volume":"84","author":"Kreipe","year":"2000","journal-title":"Med Clin North Am"},{"key":"R39-2-20210129","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine.","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"R40-2-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1742-1241.1997.tb11411.x","article-title":"SSRIs and hyponatraemia.","volume":"51","author":"Lane","year":"1997","journal-title":"Br J Clin Pract"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.41.8.713","article-title":"Water intoxication in epileptic patients receiving carbamazepine.","volume":"41","author":"Perucca","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R42-2-20210129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","article-title":"Risk factors for the development of hyponatremia in psychiatric inpatients.","volume":"155","author":"Siegler","year":"1995","journal-title":"Arch Intern Med"},{"key":"R43-2-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00045391-200607000-00014","article-title":"Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH).","volume":"13","author":"Bachu","year":"2006","journal-title":"Am J Ther"},{"key":"R44-2-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJMc062840","article-title":"Hyponatremia associated with escitalopram.","volume":"356","author":"Covyeou","year":"2007","journal-title":"N Engl J Med"},{"key":"R45-2-20210129","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1345\/aph.1G293","article-title":"Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.","volume":"40","author":"Jacob","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"7A","key":"R47-2-20210129","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjmed.2006.05.006","article-title":"Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.","volume":"119","author":"Robertson","year":"2006","journal-title":"Am J Med"},{"key":"R48-2-20210129","first-page":"1465","article-title":"The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients.","volume":"81","author":"Goldman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-2-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.1997.01830170069010","article-title":"Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia.","volume":"54","author":"Goldman","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R50-2-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-1781(00)00243-2","article-title":"Roles of arginine vasopressin and atrial natriuretic peptide in polydipsia-hyponatremia of schizophrenic patients.","volume":"101","author":"Kawai","year":"2001","journal-title":"Psychiatry Res"},{"key":"R51-2-20210129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/qjmed\/95.7.431","article-title":"Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) ingestion.","volume":"95","author":"Hartung","year":"2002","journal-title":"QJM"},{"key":"R52-2-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2006.10.027","article-title":"Exertional hyponatremia in marathon runners is associated with inappropriate secretion of arginine vasopressin.","volume":"120","author":"Siegel","year":"2007","journal-title":"Am J Med"},{"key":"R53-2-20210129","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.amjmed.2006.05.014","article-title":"Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.","volume":"119","author":"Palm","year":"2006","journal-title":"Am J Med"},{"key":"R54-2-20210129","first-page":"149","article-title":"Therapeutic recommendations for management of severe hyponatremia: currents concepts on pathogenesis and prevention of neurologic complications.","volume":"46","author":"Soupart","year":"1996","journal-title":"Clin Nephrol"},{"key":"R55-2-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.me.44.020193.001445","article-title":"Control of brain volume during hyperosmolar and hypoosmolar conditions.","volume":"44","author":"Gullans","year":"1993","journal-title":"Annu Rev Med"},{"key":"R56-2-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/schbul\/20.2.375","article-title":"Multidisciplinary approach to psychosis, intermittent hyponatremia, and polydipsia.","volume":"20","author":"Leadbetter","year":"1994","journal-title":"Schizophr Bull"},{"issue":"suppl 23","key":"R57-2-20210129","first-page":"25","article-title":"Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.","volume":"60","author":"Velligan","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"suppl 12","key":"R58-2-20210129","first-page":"3","article-title":"Measuring outcome in schizophrenia: differences among the atypical antipsychotics.","volume":"59","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R59-2-20210129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1176\/ajp.2006.163.7.1153","article-title":"Persistent auditory hallucinations that are unresponsive to antipsychotic drugs.","volume":"163","author":"Nicolson","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R60-2-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0033291798008010","article-title":"Anxiety, depression, psychotropic drug use and cognitive impairment.","volume":"29","author":"Paterniti","year":"1999","journal-title":"Psychol Med"},{"key":"R61-2-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15622970510029894","article-title":"Frequency and characteristics of recurrent major depressed patients with unimpaired executive function.","volume":"6","author":"Stordal","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"R62-2-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0149-2918(97)80082-3","article-title":"Impact of newer antipsychotics on outcomes in schizophrenia.","volume":"19","author":"Keks","year":"1997","journal-title":"Clin Ther"},{"issue":"suppl 2","key":"R63-2-20210129","first-page":"24","article-title":"Treating generalized anxiety disorder.","volume":"64","author":"Gorman","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R64-2-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00131746-200101000-00005","article-title":"Which side effects really matter Screening for common and distressing side effects of antipsychotic medications.","volume":"7","author":"Weiden","year":"2001","journal-title":"J Psychiatr Pract"},{"key":"R65-2-20210129","first-page":"154","article-title":"Treatment strategies in the polydipsia-hyponatremia syndrome.","volume":"55","author":"Vieweg","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"suppl 1","key":"R66-2-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000065371","article-title":"Therapeutic approach to hyponatremia.","volume":"92","author":"Han","year":"2002","journal-title":"Nephron"},{"key":"R67-2-20210129","first-page":"1056","article-title":"The hyponatremic patient: a systematic approach to laboratory diagnosis.","volume":"166","author":"Milionis","year":"2002","journal-title":"CMAJ"},{"key":"R68-2-20210129","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S1357-2725(03)00139-0","article-title":"The syndrome of inappropriate antidiuretic hormone secretion.","volume":"35","author":"Baylis","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"issue":"7A","key":"R69-2-20210129","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.amjmed.2006.05.012","article-title":"Exercise-associated hyponatremia: role of cytokines.","volume":"119","author":"Siegel","year":"2006","journal-title":"Am J Med"},{"key":"R70-2-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1345\/aph.1H502","article-title":"Hyponatremia: current treatment strategies and the role of vasopressin antagonists.","volume":"41","author":"Cawley","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R72-2-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.jsm.0000174702.23983.41","article-title":"for the Exercise-Associated Hyponatremia (EAH) Consensus Panel. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa, 2005.","volume":"15","author":"Hew-Butler","year":"2005","journal-title":"Clin J Sport Med"},{"key":"R73-2-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM200507283530424","article-title":"Hyponatremia in marathon runners Letter.","volume":"353","author":"Ayus","year":"2005","journal-title":"N Engl J Med"},{"key":"R74-2-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00007256-200737040-00049","article-title":"Hypertonic (3) sodium chloride for emergent treatment of exercise-associated hypotonic encephalopathy.","volume":"37","author":"Siegel","year":"2007","journal-title":"Sports Med"},{"key":"R75-2-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000047939","article-title":"Central pontine myelinolysis.","volume":"47","author":"Lampl","year":"2002","journal-title":"Eur Neurol"},{"key":"R76-2-20210129","first-page":"349","article-title":"High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients.","volume":"55","author":"Tanneau","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"11A","key":"R77-2-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations.","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"R78-2-20210129","first-page":"151","article-title":"Do electrolyte-containing beverages improve water imbalance in hyponatremic schizophrenics.","volume":"55","author":"Goldman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R79-2-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/jnp.11.1.86","article-title":"Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome.","volume":"11","author":"Canuso","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R80-2-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/ajp.153.3.445b","article-title":"Clozapine treatment of a schizophrenic patient with polydipsia and hyponatremia.","volume":"153","author":"Wakefield","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R81-2-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4088\/JCP.v59n0803","article-title":"Absence of changes in antidiuretic hormone, angiotensin II, and atrial natriuretic peptide with clozapine treatment of polydipsia-hyponatremia: 2 case reports.","volume":"59","author":"Verghese","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R82-2-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004714-199608000-00010","article-title":"Clozapine reduces water-drinking behavior in schizophrenic patients with polydipsia.","volume":"16","author":"Fuller","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R83-2-20210129","first-page":"123","article-title":"Clozapine treatment in polydipsia and intermittent hyponatremia.","volume":"57","author":"Spears","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"R84-2-20210129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.jcp.0000145337.07676.2f","article-title":"Absence of effect of olanzapine on primary polydipsia: results of a double-blind, randomized study.","volume":"24","author":"Goldman","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R85-2-20210129","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1067\/mhj.2003.154","article-title":"Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.","volume":"145","author":"Gheorghiade","year":"2003","journal-title":"Am Heart J"},{"issue":"suppl 18S","key":"R86-2-20210129","first-page":"480S","article-title":"Efficacy and safety of the vasopressin antagonist conivaptan in patients with euvolemic hyponatremia evaluated in a phase III clinical trial.","volume":"24","author":"Verbalis","year":"2006","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"R87-2-20210129","first-page":"A64","article-title":"Conivaptan for the treatment of hyponatremia in hospitalized patients: results from an open-label study Abstract.","volume":"34","author":"Verbalis","year":"2007","journal-title":"Crit Care Med"},{"key":"R88-2-20210129","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1AV2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.","volume":"91","author":"Ghali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R89-2-20210129","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"for the SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"R90-2-20210129","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure. Results from a double-blind, randomized trial.","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"R91-2-20210129","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure. A randomized controlled trial.","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"R92-2-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"985 Study Group. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.","volume":"37","author":"Wong","year":"2003","journal-title":"Hepatology"},{"key":"R93-2-20210129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2215\/CJN.00160106","article-title":"Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.","volume":"1","author":"Soupart","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"abstr suppl","key":"R94-2-20210129","first-page":"345","article-title":"Treatment of hyponatremia in patients with SIADH or CHF with intravenous conivaptan (YM087), a new combined vasopressin V1AV2 receptor antagonist, abstract.","volume":"21","author":"Abraham","year":"2000","journal-title":"Eur Heart J"},{"key":"R95-2-20210129","first-page":"434","article-title":"Vasopressin V2-receptor blockade with tolvaptan in schizophrenic patients with hyponatremia: results from a double-blind, randomized trial Abstract.","volume":"33","author":"Josiassen","year":"2007","journal-title":"Schizophr Bull"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00023727-200801000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:38Z","timestamp":1786035038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00023727-200801000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1080\/10673220801924308","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}